Page last updated: 2024-10-24

celecoxib and Weight Gain

celecoxib has been researched along with Weight Gain in 4 studies

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research Excerpts

ExcerptRelevanceReference
"Previous studies reported promising efficacy for celecoxib in the treatment of cancer cachexia."9.27Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. ( Ala, S; Alipour, A; Borhani, S; Janbabai, G; Kouchaki, B; Salehifar, E, 2018)
" This study evaluated the effects of celecoxib 200 mg/day and rofecoxib 25 mg/day on blood pressure (BP) and edema in a 6-week, randomized, parallel-group, double-blind study in patients > or =65 years of age with osteoarthritis who were treated with fixed antihypertensive regimens."9.10Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. ( Bello, AE; Fort, JG; Puma, JA; Whelton, A; White, WB, 2002)
"Previous studies reported promising efficacy for celecoxib in the treatment of cancer cachexia."5.27Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. ( Ala, S; Alipour, A; Borhani, S; Janbabai, G; Kouchaki, B; Salehifar, E, 2018)
"A combination of celecoxib and selenium was used in a randomized double-blind Phase II trial as a preliminary study to a multicenter Phase III colorectal cancer chemoprevention trial using these two agents together."5.11Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial. ( Alberts, DS; Choquette, K; Chow, HH; Fish, A; Francis, J; Frank, DH; Gracie, D; Guillen, JM; Roe, DJ, 2004)
" This study evaluated the effects of celecoxib 200 mg/day and rofecoxib 25 mg/day on blood pressure (BP) and edema in a 6-week, randomized, parallel-group, double-blind study in patients > or =65 years of age with osteoarthritis who were treated with fixed antihypertensive regimens."5.10Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. ( Bello, AE; Fort, JG; Puma, JA; Whelton, A; White, WB, 2002)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kouchaki, B1
Janbabai, G1
Alipour, A1
Ala, S1
Borhani, S1
Salehifar, E1
Whelton, A1
White, WB1
Bello, AE1
Puma, JA1
Fort, JG1
Frank, DH1
Roe, DJ1
Chow, HH1
Guillen, JM1
Choquette, K1
Gracie, D1
Francis, J1
Fish, A1
Alberts, DS1
Cerchietti, LC1
Navigante, AH1
Castro, MA1

Trials

4 trials available for celecoxib and Weight Gain

ArticleYear
Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:7

    Topics: Anorexia; Antineoplastic Agents, Hormonal; Cachexia; Celecoxib; Combined Modality Therapy; Double-Bl

2018
Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
    The American journal of cardiology, 2002, Nov-01, Volume: 90, Issue:9

    Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure;

2002
Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004, Volume: 13, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anticarcinogenic Agents; Celecoxib; Colorectal Neoplasms; Double-

2004
Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Nutrition and cancer, 2007, Volume: 59, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Appetite; C-Reactive Protein; Cachexia; Celecoxib; Cohort Studies; C

2007